Related Experiment Video

Updated: Aug 11, 2026

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on: May 22, 2020

Beneficial response to rituximab in refractory Felty Syndrome

Nicole Weinreb, Arthur Rabinowitz, Paul F Dellaripa

Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases

|February 18, 2006

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment-an expert group consensus statement.

The Lancet. Respiratory medicine·2026

Deep learning-derived quantitative interstitial abnormalities in early rheumatoid arthritis and healthy controls: A multicenter, prospective cross-sectional study.

medRxiv : the preprint server for health sciences·2026

A CD57+CD8+ T cell subset links T cell cytotoxicity to fibrotic lung disease in systemic sclerosis.

The Journal of clinical investigation·2026

Implementation of a heat alert system for clinical staff in an ambulatory setting: A pilot project.

The journal of climate change and health·2026

Combining Pirfenidone With Mycophenolate Mofetil for Systemic Sclerosis-Related Interstitial Lung Disease (Scleroderma Lung Study III): An Investigator-Initiated, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.

ACR open rheumatology·2025

The Effects of Extreme Heat on Individuals with Rheumatic Conditions: Equity Considerations.

Rheumatic diseases clinics of North America·2025

See all related articles